RCE in Sourcecodester Drug Recommendation System
CVE-2026-108919
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. The impacted element is an unknown function of the file Auth/add_student.php of the component Student Registration. This manipulation of the argument txtname/txtpassword/txtemail/txtphone/txtprevious_school causes cross site scripting. The attack can be initiated remotely. The exploit has been made available to the public and could be used for attacks.
Vulnerability class: XSS (Cross-Site Scripting)
Published .
CVSS v3 metric
CVSS v3 base score 4.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- vuldb.com/vuln/416732 (technical-description, vdb-entry)
- vuldb.com/vuln/416732/cti (signature, permissions-required)
- vuldb.com/cve/CVE-2026-108919 (third-party-advisory)
- vuldb.com/submit/970936 (third-party-advisory)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-108919?
- CVE-2026-108919 is a medium-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-site Scripting. CVSS score: 4.3/10. Published 2026-10-12.
- How severe is CVE-2026-108919?
- Medium severity. CVSS v3 base score is 4.3 out of 10.